Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday

Bone Biologics (NASDAQ:BBLG) is expected to announce its earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of ($0.65) per share for the quarter.

Bone Biologics Price Performance

Bone Biologics stock opened at $1.02 on Wednesday. The firm has a 50-day moving average price of $1.06 and a two-hundred day moving average price of $1.41. Bone Biologics has a 52-week low of $0.80 and a 52-week high of $4.49.

Bone Biologics Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.